VitalSigns
Return to the Blog Homepage

Tag Archives: Drug Pricing

June 5, 2017

0 Comments

Written by

Categories: The Week That Was

Tags: , , ,

The Week That Was: Crises in Communications

Well folks, it’s officially summertime in the city…but the livin’ is not exactly easy for The Week That Was editorial team! There are just too many hot headlines to choose from. We busted out summer wardrobes and endured the first...

March 6, 2017

0 Comments

Written by

Categories: The Week That Was

Tags: , ,

The Week That Was: Crises in Communications

Storylines last week focused on drama, mystery, and intrigue. Our top case revolves around the case of the missing healthcare bill. Following President Trump’s address that focused heavily on overhauling healthcare, the GOP promised to unveil its replacement to the...

February 6, 2017

0 Comments

Written by

Categories: The Week That Was

Tags: , ,

The Week That Was: Crises in Communications

Grab your foam fingers and jerseys, people: it’s The Week That Was Super Bowl edition! Check out these stories taking the field this week: There was a major huddle at the White House between two previously opposing teams: POTUS and...

December 8, 2016

0 Comments

Written by

Categories: The Week That Was

Tags: , ,

The Week That Was: Crises in Communications

WE’RE BACK! Reinvigorated from turkey, stuffing and football, we’re back with our irreverent take on the forced and unforced issues facing the healthcare industry. This week, we look at how some of the industry’s normally mild-mannered CEOs sparred over drug...

November 7, 2016

0 Comments

Written by

Categories: The Week That Was

Tags: , ,

The Week That Was: Crises in Communications

Readers, We’re feeling a bit plucky this evening! We report on how “big chicken” may be artificially keeping the price of poultry high. The pharma industry and ICER duked it out in the press…meanwhile, the FDA can’t get prospective hires...

October 31, 2016

0 Comments

Written by

Categories: The Week That Was

Tags: ,

The Week That Was: Crises in Communications

Happy Halloween, Readers. Last week we saw PhRMA go trick-or-treating for cash. Activist investors tried to spook the biopharmaceutical industry into greater transparency on drug prices. And a new poll showed that Americans rank drug costs a top the list...

October 17, 2016

0 Comments

Written by

Categories: The Week That Was

Tags: , , ,

The Week That Was: Crises in Communications

It is time for the latest edition of The Week That Was, our rehash of the real and sometimes surreal moments in healthcare headlines. This week, we profile how St. Jude’s pacemakers are not up to speed and potentially giving...

October 10, 2016

0 Comments

Written by

Categories: The Week That Was

Tags: , , ,

The Week That Was: Crises in Communications

Despite reputational polls indicating pharmaceuticals are currently among the least trusted industries in the country, we are reminded that it could always be worse… we could be in political PR. Last week, Goldman Sachs warned it’s time for drug makers...

October 4, 2016

0 Comments

Written by

Categories: The Week That Was

Tags: ,

The Week That Was: Crises in Communications

WARNING: We’re getting into heavy stuff this week, like compassionate use, 340B pricing policy and value frameworks, but we promise you don’t need to be an economics Ph.D. to follow along. We often get asked to pull out our crystal...

Med-Sci Matters by Dr. Dave

This installment has a somewhat unusual collection of topics – how a recent FDA approval may augur a paradigm shift in the drug review process by giving more weight to patient points of view, drug pricing, FDA hearings on disseminating off-label drug...